Chemed Corp
Change company Symbol lookup
Select an option...
CHE Chemed Corp
ASTA WorldFlix Inc
$NQDM15LMCADN Nasdaq Developed Markets Telecommuni
BFZ BlackRock California Municipal Income Trust
CAR Avis Budget Group Inc
GIS General Mills Inc
VLN Valens Semiconductor Ltd
CIF MFS? Intermediate High Income Fund
LVOXW LiveVox Holdings Inc *W EXP 06/18/2026
SASR Sandy Spring Bancorp Inc
Go

Health Care : Health Care Providers & Services | Mid Cap Blend
Company profile

Chemed Corporation purchases, operates, and divests subsidiaries engaged in diverse business activities. The Company operates through two segments: the VITAS segment and Roto-Rooter segment. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. The Company's VITAS business is operated in the state of Florida. Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. Its services are provided through a network of company-owned branches, independent contractors, and franchisees. The Company's subsidiaries include Chemed RT, Inc., Comfort Care Holdings Co., Comfort Care Holdings Co. and others.

Closing Price
$430.12
Day's Change
12.45 (2.98%)
Bid
--
Ask
--
B/A Size
--
Day's High
431.43
Day's Low
417.61
Volume
(Light)
Volume:
94,641

10-day average volume:
118,739
94,641

Coronavirus tally: Global cases of COVID-19 near 235 million and J&J to seek FDA authorization for booster

6:32 am ET October 4, 2021 (MarketWatch)
Print

The global tally for the coronavirus-borne illness climbed above 234.9 million on Monday, while the death toll rose above 4.8 million, according to data aggregated by Johns Hopkins University. The U.S. continues to lead the world with a total of 43.7 million cases and 701,176 deaths, after passing 700,000 late Friday. The U.S. is now averaging almost 2,000 deaths a day, according to a New York Times tracker, , a slight improvement over recent trends and new cases and hospitalizations are declining. Johnson & Johnson (JNJ) and Moderna (MRNA) have applied for authorization from the FDA for their COVID-19 vaccine boosters and an advisory committee will discuss them at a meeting scheduled for Oct. 14 and Oct. 15. Separately, the CEO of BioNTEch (BNTX) told the FT that COVID-19 is likely to continue mutating to the point where it can escape vaccines and immune systems and that a new vaccine may be required in the future India is second by cases after the U.S. at 33.8 million and has suffered 448,997 deaths. Brazil has second highest death toll at 597,948 and 21.5 million cases. In Europe, Russia has most fatalities at 207,056, followed by the U.K. at 137,338.

-Ciara Linnane

	

(END) Dow Jones Newswires

October 04, 2021 06:32 ET (10:32 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.